Product Pipeline

Overview

Our initial product pipeline is focused on three therapeutic molecules.

These products include BTI-320, IPOXYN™ and OXYFEX™.

Construct Indication Preclinical Phase 1 Phase 2 Phase 3

BTI-320

Type 2 Diabetes

Pre-Clinical Phase completed
Phase 1 completed
Phase 2 in progress
Phase 3 not started

Ipoxyn™

Lower limb vascular complications of diabetes

Pre-Clinical Phase in progress

Oxyfex™

Veterinary ischemic tissue

Pre-Clinical Phase in progress